[1]苏叶舟,徐祖滢,向卉芬,等.C反应蛋白与白蛋白之比与宫颈癌患者预后的关系[J].医学信息,2020,33(08):80-83.[doi:10.3969/j.issn.1006-1959.2020.08.026]
　SU Ye-zhou,XU Zu-ying,XIANG Hui-fen,et al.Relationship Between CAR and Prognosis of Cervical Cancer Patients[J].Medical Information,2020,33(08):80-83.[doi:10.3969/j.issn.1006-1959.2020.08.026]
点击复制

C反应蛋白与白蛋白之比与宫颈癌患者预后的关系()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年08期
页码:
80-83
栏目:
论著
出版日期:
2020-04-15

文章信息/Info

Title:
Relationship Between CAR and Prognosis of Cervical Cancer Patients
文章编号:
1006-1959（2020）08-0080-04
作者:
苏叶舟; 徐祖滢; 向卉芬; 等
（1.安徽医科大学第一附属医院妇产科，安徽 合肥 230032；2.国家卫生健康委配子及生殖道异常研究重点实验室，安徽 合肥 230032；3.出生人口健康教育部重点实验室，安徽 合肥 230032；4.生殖健康与遗传安徽省重点实验室，安徽 合肥 230032；5.安徽省生命资源保存与人工器官工程技术研究中心<安徽医科大学>，安徽 合肥 230032）
Author(s):
SU Ye-zhou; XU Zu-ying; XIANG Hui-fen; et al
(1.Department of Obstetrics and Gynecology,the First Affiliated Hospital of Anhui Medical University,Hefei 230032,Anhui,China;2.Key Laboratory of Gamete and Reproductive Tract Abnormality Research,National Health Commission,Hefei 230032,Anhui,China;3.Key Laboratory of Birth Population Health Ministry of Education,Hefei 230032,Anhui,China;4.Anhui Provincial Key Laboratory of Reproductive Health and Genetics,Hefei 230032,Anhui,China;5.Anhui Provincial Research Center for Life Resources Conservation and Artificial Organ Engineering Technology ,Hefei 230032,Anhui,China)
关键词:
C反应蛋白与白蛋白之比; 宫颈癌; 预后因子
Keywords:
Ratio of C-reactive protein to albumin; Cervical cancer; Prognostic factor
分类号:
R737.33
DOI:
10.3969/j.issn.1006-1959.2020.08.026
文献标志码:
A
摘要:
目的 探讨C反应蛋白与白蛋白之比（CAR）与宫颈癌患者淋巴结转移和预后的关系。方法 回顾性分析2008年1月~2013年1月安徽医科大学第一附属医院收治的407例行宫颈癌根治术ⅠB~ⅡA期宫颈癌患者患者的临床病理资料，根据CAR临界值分为CAR高组及CAR低组，比较两组临床资料，并采用Cox单因素和多因素分析宫颈癌患者预后的相关因素，采用Kaplan-Meier法分析两组生存率。结果 ROC曲线分析显示，CAR截值为0.15，ROC曲线下的面积分别为0.709，CAR随访时间、敏感度、特异度分别为5年，0.756，0.894。两组年龄、肿瘤大小、病理类型比较，差异无统计学意义（P＞0.05）；两组辅助治疗、肿瘤分期、淋巴结是否转移比较，差异有统计学意义（P＜0.05）。Cox单因素分析显示，宫颈癌患者的预后与肿瘤分期、辅助治疗、淋巴结转移、NLR、PLR、PNI、CAR相关（P＜0.05）；Cox多因素分析显示，肿瘤分期、辅助治疗和CAR是影响宫颈癌患者预后的独立因素（P＜0.05）。Kaplan-Meier生存曲线显示，CAR高组生存率低于CAR低组，差异有统计学意义（P＜0.05）。结论CAR值是影响宫颈癌患者预后的独立因素，其预测价值较好。
Abstract:
Objective To explore the relationship between the ratio of C-reactive protein to albumin (CAR) and lymph node metastasis and prognosis in patients with cervical cancer.Methods A retrospective analysis of the clinicopathological data of 407 patients with cervical cancer stage ⅠB ~ ⅡA who were admitted to the First Affiliated Hospital of Anhui Medical University from January 2008 to January 2013 was divided into CAR high groups according to the CAR threshold compared with the CAR low group, the clinical data of the two groups were compared. Cox univariate and multivariate were used to analyze the prognostic factors of cervical cancer patients. The Kaplan-Meier method was used to analyze the survival rates of the two groups.Results ROC curve analysis showed that the CAR cut-off value was 0.15, the area under the ROC curve was 0.709, and the CAR follow-up time, sensitivity, and specificity were 5 years, 0.756, and 0.894, respectively. There was no statistically significant difference in age, tumor size, and pathological type between the two groups (P>0.05); there were statistically significant differences in adjuvant therapy, tumor stage, and lymph node metastasis between the two groups (P<0.05). Cox single factor analysis showed that the prognosis of cervical cancer patients was related to tumor staging, adjuvant therapy, lymph node metastasis, NLR, PLR, PNI, CAR (P<0.05); Cox multivariate analysis showed that tumor staging, adjuvant therapy, and CAR independent factors for the prognosis of cervical cancer patients (P<0.05). The Kaplan-Meier survival curve showed that the survival rate of the high CAR group was lower than that of the low CAR group,the difference was statistically significant (P<0.05).Conclusion CAR value is an independent factor affecting the prognosis of cervical cancer patients, and its predictive value is good.

参考文献/References:

[1]Siegel RL,Miller KD,Jemal A.Cancer statistics,2018[J].Ca A Cancer Journal for Clinicians,2018,68(1):7.[2]Niu C,Sun X,Zhang W,et al.NR2F6 Expression Correlates with Pelvic Lymph Node Metastasis and Poor Prognosis in Early-Stage Cervical Cancer[J].International Journal of Molecular Sciences,2016,17(10):1694.[3]Deivendran S,Marzook KH,Radhakrishna Pillai M.The role of inflammation in cervical cancer[J].Adv Exp Med Biol,2014(816):377-399.[4]Zhang L,Su Y,Chen Z,et al.The prognostic value of preoperative inflammation-based prognostic scores and nutritional status for overall survival in resected patients with nonmetastatic Siewert type Ⅱ/Ⅲ adenocarcinoma of esophagogastric junction[J].Medicine(Baltimore),2017,96(30):e7647.[5]Nazha B,Moussaly E,Zaarour M,et al.Hypoalbuminemia in colorectal cancer prognosis:Nutritional marker or inflammatory surrogate[J].World J Gastrointest Surg,2015,7(12):370-377.[6]Zheng RR,Huang M,Jin C,et al.Cervical cancer systemic inflammation score:a novel predictor of prognosis[J].Oncotarget,2016,7(12):15230-15242.[7]Templeton AJ,Ace O,McNamara MG,et al.Prognostic role of platelet to lymphocyte ratio in solid tumors:a systematic review and meta-analysis[J].Cancer Epidemiol Biomarkers Prev,2014,23(7):1204-1212.[8]Dolan RD,McSorley ST,Horgan PG,et al.The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer:Systematic review and meta-analysis[J].Crit Rev Oncol Hematol,2017(116):134-146.[9]Haraga J,Nakamura K,Omichi C,et al.Pretreatment prognostic nutritional index is a significant predictor of prognosis in patients with cervical cancer treated with concurrent chemoradiotherapy[J].Molecular and Clinical Oncology,2016(5):567-574.[10]Sun K,Chen S,Xu J,et al.The prognostic significance of the prognostic nutritional index in cancer:a systematic review and meta-analysis[J].Journal of Cancer Research and Clinical Oncology,2014,140(9):1537-1549.[11]Kinoshita A,Onoda H,Imai N,et al.The C-Reactive Protein/Albumin Ratio,a Novel Inflammation-Based Prognostic Score,Predicts Outcomes in Patients with Hepatocellular Carcinoma[J].Annals of Surgical Oncology,2015,22(3):803-810.[12]Zhou T,Zhan J,Hong S,et al.Ratio of C-Reactive Protein/Albumin is An Inflammatory Prognostic Score for Predicting Overall Survival of Patients with Small-cell Lung Cancer[J].Scientific Reports,2015(5):10481.[13]Shibutani M,Maeda K,Nagahara H,et al.Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer[J].Anticancer Research,2016,36(3):995-1002.[14]Otowa Y,Nakamura T,Yamamoto M,et al.C-reactive protein to albumin ratio is a prognostic factor for patients with Stage /Ⅲ esophageal squamous cell cancer[J].Dis Esophagus,2017,30(12):1-5. [15]Stevens L,Pathak S,Nunes QM,et al.Prognostic significance of pre-operative C-reactive protein and the neutrophil-lymphocyte ratio in resectable pancreatic cancer:a systematic review[J].HPB(Oxford),2015,17(4):285-291.[16]Bodner-Adler B,Kimberger O,Schneidinger C,et al.Prognostic Significance of Pre-treatment Serum C-Reactive Protein Level in Patients with Adenocarcinoma of the Uterine Cervix[J].Anticancer Research,2016,36(9):4691-4696.[17]Polterauer S,Grimm C,Zeillinger R,et al.Association of C-Reactive Protein(CRP)Gene Polymorphisms,Serum CRP Levels and Cervical Cancer Prognosis[J].Anticancer Research,2011,31(6):2259-2264.[18]Kumar A,Jain M,Yadav A,et al.Pattern of mismatch repair protein loss and its clinicopathological correlation in colorectal cancer in North India[J].S Afr J Surg,2018,56(1):25-29.[19]Zimmerman MA,Selzman CH,Cothren C,et al.Diagnostic implications of C-reactive protein[J].Arch Surg,2003,138(2):220-224.[20]Friel G,Liu CS,Kolomeyevskaya NV,et al.Aspirin and Acetaminophen Use and the Risk of Cervical Cancer[J].Journal of Lower Genital Tract Disease,2015,19(3):189-193.[21]Hindler K,Cleeland CS,Rivera E,et al.The role of statins in cancer therapy[J].Oncologist,2006,11(3):306-315. [22]Trikha M,Corringham R,Klein B,et al.Targeted anti-interleukin-6 monoclonal antibody therapy for cancer:a review of the rationale and clinical evidence[J].Clin Cancer Res,2003,9(13):4653-4665.

相似文献/References:

[1]廖加群,曹 雪,陈燕平,等.宫颈癌盆腔淋巴结转移分布及危险因素分析[J].医学信息,2018,31(03):25.[doi:10.3969/j.issn.1006-1959.2018.03.008]
　LIAO Jia-qun,CAO Xue,CHEN Yan-ping,et al.Distribution and Risk Factors of Pelvic Lymph Node Metastasis in Cervical Cancer[J].Medical Information,2018,31(08):25.[doi:10.3969/j.issn.1006-1959.2018.03.008]
[2]徐 洁.宫颈癌筛查及预防的研究进展[J].医学信息,2018,31(09):70.[doi:10.3969/j.issn.1006-1959.2018.09.022]
　XU Jie.Advances in Screening and Prevention of Cervical Cancer[J].Medical Information,2018,31(08):70.[doi:10.3969/j.issn.1006-1959.2018.09.022]
[3]蔡亚磊,邓思雨,杨 健.宫颈癌放疗增敏的研究现状[J].医学信息,2022,35(09):65.[doi:10.3969/j.issn.1006-1959.2022.09.016]
　CAI Ya-lei,DENG Si-yu,YANG Jian.Research Status of Radiotherapy Sensitization for Cervical Cancer[J].Medical Information,2022,35(08):65.[doi:10.3969/j.issn.1006-1959.2022.09.016]
[4]车 莹.HPV感染与宫颈病变相关性的研究[J].医学信息,2022,35(09):84.[doi:10.3969/j.issn.1006-1959.2022.09.021]
　CHE Ying.Study on the Correlation Between HPV Infection and Cervical Lesions[J].Medical Information,2022,35(08):84.[doi:10.3969/j.issn.1006-1959.2022.09.021]
[5]曹 亮,郝 朋,李阳明,等.宫颈癌所致输尿管梗阻患者输尿管支架置入成功率影响因素的Meta分析[J].医学信息,2022,35(09):124.[doi:10.3969/j.issn.1006-1959.2022.09.031]
　CAO Liang,HAO Peng,LI Yang-ming,et al.Meta Analysis of Factors Influencing Success Rate of Ureteral Stent Implantation in Patients with Ureteral Obstruction Caused by Cervical Cancer[J].Medical Information,2022,35(08):124.[doi:10.3969/j.issn.1006-1959.2022.09.031]
[6]覃念群,刘 楷,米镜霖,等.基于生物信息学分析筛选与宫颈癌预后相关的关键基因[J].医学信息,2022,35(10):8.[doi:10.3969/j.issn.1006-1959.2022.10.002]
　QIN Nian-qun,LIU Kai,MI Jing-lin,et al.Screening Key Genes Related to the Prognosis of Cervical Cancer Based on Bioinformatics Analysis[J].Medical Information,2022,35(08):8.[doi:10.3969/j.issn.1006-1959.2022.10.002]
[7]黄 花,徐冬冬,章丽霞.TGF-β1在宫颈癌中的研究进展[J].医学信息,2018,31(12):31.[doi:10.3969/j.issn.1006-1959.2018.12.011]
　HUANG Hua,XU Dong-dong,ZHANG Li-xia.Research Progress of TGF-β1 in Cervical Cancer[J].Medical Information,2018,31(08):31.[doi:10.3969/j.issn.1006-1959.2018.12.011]
[8]夏易曼娜,李虎成.腹腔镜下宫颈癌根治术与传统开腹手术的对比研究[J].医学信息,2018,31(12):115.[doi:10.3969/j.issn.1006-1959.2018.12.036]
　XIA Yi-manna,LI Hu-cheng.Comparative Study of Laparoscopic Radical Resection of Cervical Cancer and Traditional Open Surgery[J].Medical Information,2018,31(08):115.[doi:10.3969/j.issn.1006-1959.2018.12.036]
[9]杨 军,王翠平,李 龙,等.义安区体检HPV-DNA筛查结果分析[J].医学信息,2018,31(14):136.[doi:10.3969/j.issn.1006-1959.2018.14.041]
　YANG Jun,WANG Cui-ping,LI Long,et al.Analysis of the Results of HPV-DNA Screening in the Medical Examination of Yian District[J].Medical Information,2018,31(08):136.[doi:10.3969/j.issn.1006-1959.2018.14.041]
[10]王双英,张 娜,刘 芳.具有高危复发因素的早期宫颈癌术后辅助治疗进展[J].医学信息,2018,31(15):33.[doi:10.3969/j.issn.1006-1959.2018.15.012]
　WANG Shuang-ying,ZHANG Na,LIU Fang.Advances in Postoperative Adjuvant Therapy for Early Cervical Cancer with High Risk of Recurrence[J].Medical Information,2018,31(08):33.[doi:10.3969/j.issn.1006-1959.2018.15.012]

更新日期/Last Update: 2020-04-15